We are live on ! Find out more
NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $121M
1-Year Est. Return 56.89%
This Fund
S&P 500
This Quarter Est. Return
+7.82%
1 Year Est. Return
+56.89%
3 Year Est. Return
+244.35%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$52.1M
Cap. Flow
+$45.3M
Cap. Flow %
40.51%
Top 10 Hldgs %
79.75%
Holding
28
New
4
Increased
–
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
EVMN
Evommune Inc
EVMN
+$27.1M
2
MPLT
MapLight Therapeutics
MPLT
+$16.3M
3
PCOR icon
Procore
PCOR
+$3.94M
4
HELP
Cybin Inc
HELP
+$2.96M

Top Sells

Rank Stock Value
1
JOBY icon
Joby Aviation
JOBY
+$3.51M
2
RKLB icon
Rocket Lab Corp
RKLB
+$1.47M

Sector Composition

Rank Sector Weight
1 Healthcare 94.54%
2 Technology 3.47%
3 Industrials 0.24%
4 Materials 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVMN
1
Evommune Inc
EVMN
$409M
$24.7M 22.08%
+1,441,032
New +$27.1M
MPLT
2
MapLight Therapeutics
MPLT
$636M
$17.1M 15.27%
+971,253
New +$16.3M
OCS icon
3
Oculis Holding
OCS
$677M
$10.3M 9.2%
514,702
– –
MDGL icon
4
Madrigal Pharmaceuticals
MDGL
$11.4B
$6.91M 6.19%
11,872
– –
LBRX
5
LB Pharmaceuticals
LBRX
$1.17B
$6.68M 5.98%
300,000
– –
INCY icon
6
Incyte
INCY
$24.9B
$5.83M 5.22%
59,022
– –
RYTM icon
7
Rhythm Pharmaceuticals
RYTM
$7.25B
$5.26M 4.71%
49,120
– –
ONC
8
BeOne Medicines Ltd
ONC
$33.4B
$4.78M 4.28%
15,722
– –
PCOR icon
9
Procore
PCOR
$8.12B
$3.88M 3.47%
+53,299
New +$3.94M
HELP
10
Cybin Inc
HELP
$505M
$3.76M 3.37%
+460,000
New +$2.96M
ASND icon
11
Ascendis Pharma A/S
ASND
$16.5B
$2.9M 2.6%
13,600
– –
ACAD icon
12
Acadia Pharmaceuticals
ACAD
$4.55B
$2.75M 2.46%
102,984
– –
RXRX icon
13
Recursion Pharmaceuticals
RXRX
$1.61B
$2.43M 2.18%
595,287
– –
LAB icon
14
Standard BioTools
LAB
$351M
$2.41M 2.16%
1,883,179
– –
KYMR icon
15
Kymera Therapeutics
KYMR
$8.8B
$2.4M 2.15%
30,875
– –
ARGX icon
16
argenx
ARGX
$54.6B
$2.35M 2.11%
2,800
– –
RVMD icon
17
Revolution Medicines
RVMD
$40.9B
$1.53M 1.37%
19,253
– –
ETHA
18
iShares Ethereum Trust ETF
ETHA
$5.6B
$1.13M 1.01%
50,549
– –
HRMY icon
19
Harmony Biosciences
HRMY
$2.08B
$1.01M 0.91%
27,049
– –
IBIT icon
20
iShares Bitcoin Trust
IBIT
$48.1B
$793K 0.71%
15,968
– –
RANI icon
21
Rani Therapeutics
RANI
$92.2M
$666K 0.6%
493,584
– –
REPL icon
22
Replimune Group
REPL
$619K 0.55%
63,719
– –
TRDA icon
23
Entrada Therapeutics
TRDA
$263M
$505K 0.45%
49,082
– –
BCYC
24
Bicycle Therapeutics
BCYC
$280M
$488K 0.44%
68,943
– –
BOLT icon
25
Bolt Biotherapeutics
BOLT
$7.47M
$319K 0.29%
58,347
– –
1
2

Similar funds

TCM
TT Capital Management Coto De Caza, California $121M AUM 1.94% 1-Year Est. Return
MAM
Mirabaud Asset Management London, United Kingdom $121M AUM 20.69% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
CCM
Candelo Capital Management New York $121M AUM 113.39% 1-Year Est. Return
CCM
CFO Capital Management Fairfield, Connecticut $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Nan Fung Group Holdings's Q4 2025 Portfolio in Review

As of Q4 2025, Nan Fung Group Holdings held 28 positions worth $112M, up 87% from $59.6M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Nan Fung Group Holdings deployed $45.3M of net new capital in Q4 2025, opening 4 new positions. Its largest new stake was Evommune Inc: 1,441,032 shares worth $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 87% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Rocket Lab Corp, an estimated $1.47M trimmed.

  • Nan Fung Group Holdings's largest Q4 2025 buy was Evommune Inc: 1,441,032 shares worth $24.7M.
  • Nan Fung Group Holdings's biggest Q4 2025 reduction was Rocket Lab Corp, cutting an estimated $1.47M.
  • Nan Fung Group Holdings fully exited Joby Aviation in Q4 2025, selling an estimated $3.51M.
  • Nan Fung Group Holdings's ten largest holdings make up 80% of its $112M portfolio in Q4 2025.
  • Nan Fung Group Holdings opened 4 new positions and closed 1 in Q4 2025.
  • Nan Fung Group Holdings's portfolio value rose 87% quarter-over-quarter to $112M.

Based on Nan Fung Group Holdings's 13F filing for Q4 2025, filed 13 Feb 2026.